GSA Capital Partners LLP Invests $306,000 in Tempus AI, Inc. (NASDAQ:TEM)

GSA Capital Partners LLP bought a new position in Tempus AI, Inc. (NASDAQ:TEM) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 5,408 shares of the company’s stock, valued at approximately $306,000.

Other hedge funds have also recently modified their holdings of the company. Sigma Planning Corp purchased a new position in shares of Tempus AI in the third quarter worth $1,323,000. Dakota Wealth Management bought a new stake in Tempus AI in the third quarter worth $1,185,000. Davidson Kempner Capital Management LP bought a new stake in Tempus AI in the second quarter worth $2,271,000. NEA Management Company LLC bought a new stake in Tempus AI in the second quarter worth $160,048,000. Finally, Exchange Traded Concepts LLC bought a new stake in Tempus AI in the third quarter worth $3,458,000.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $58.60 on Friday. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The business’s 50 day moving average is $51.94.

Analysts Set New Price Targets

TEM has been the topic of several research reports. Piper Sandler restated a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Loop Capital boosted their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. JPMorgan Chase & Co. boosted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Needham & Company LLC reiterated a “buy” rating and set a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Finally, Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $54.22.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.